| Autor: |
Julien Zuber, Isabelle André, Baptiste Lamarthée, Jean-Luc Taupin, Nicolas Pallet, Titeux M, Vinçon H, Katrin Vogt, Charbonnier S, Christophe Legendre, Marina Cavazzana, Armance Marchal, Marianne Delville, Birgit Sawitzki, Blein T, Sylvain Latour, Dany Anglicheau, Emmanuelle Six, Emmanuel Martin |
| Rok vydání: |
2020 |
| Předmět: |
|
| Popis: |
The use of chimeric antigen receptor (CAR)-engineered regulatory T cells (Tregs) has emerged as a promising strategy to promote immune tolerance in transplantation. However, in conventional T cells (Tconvs), CAR expression is often associated with tonic signaling resulting from ligand-independent baseline activation. Tonic signaling may cause CAR-T cell dysfunction, especially when the CAR structure incorporates the CD28 costimulatory domain (CSD) rather than the 4-1BB CSD.Here, we explored the impact of tonic signaling on human CAR-Tregs according to the type of CSD. Compared to CD28-CAR-Tregs, 4-1BB-CAR-Tregs showed enhanced proliferation and greater activation of MAP kinase and mTOR pathways but exhibited decreased lineage stability and reduced abilities to produce IL-10 and be restimulated through the CAR. Although both CAR-Treg populations were suppressive in vivo, cell tracking with bioluminescence imaging found longer persistence for CD28-CAR-Tregs than for 4-1BB-CAR-Tregs. This study demonstrates that CD28-CAR best preserves Treg function and survival in the context of tonic signaling, in contrast with previous findings for Tconvs.SUMMARYLamarthée et al investigated the impact of chimeric antigen receptor (CAR) tonic signaling on CAR-engineered Tregs according to the incorporated costimulatory domain (either CD28 or 4-1BB). CD28 ameliorated Treg stability, long-term survival and function compared to 4-1BB. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
